Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein (Q44571000)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 November 2006

Language	Label	Description	Also known as
English	Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein	scientific article published on 3 November 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Cassandra M James

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Mohammad Y Abdad

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Josephine P Mansfield

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Hege K Jacobsen

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Azita Rezazadeh Vind

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Philip A Stumbles

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Emmalene J Bartlett

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

3 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1856-1867

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Genetics of Influenza Viruses

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

A novel influenza A virus mitochondrial protein that induces cell death.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

DNA vaccines: progress and challenges

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

A review of vaccine research and development: human acute respiratory infections.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

DNA inoculations with HIV-1 recombinant genomes that express cytokine genes enhance HIV-1 specific immune responses

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Are all type I human interferons equivalent?

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Interferons and their actions

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

The human interferon alpha species and receptors

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Stats: transcriptional control and biological impact

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Type I interferon differential therapy for erythroleukemia: specificity of STAT activation

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Optimization of naked DNA delivery for interferon subtype immunotherapy in cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Cytokine expression in murine cytomegalovirus-induced myocarditis: modulation with interferon-alpha therapy.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Type I IFN-beta gene therapy suppresses cardiac CD8 T-cell infiltration during autoimmune myocarditis

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Transient transfection of mouse fibroblasts with type I interferon transgenes provides various degrees of protection against herpes simplex virus infection

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Interferon-beta suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Cellular immunity and memory to respiratory virus infections

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Protection and compensation in the influenza virus-specific CD8 T cell response

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Local immune responses to influenza virus infection in mice with a targeted disruption of perforin gene

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Effector CD4 and CD8 T-cell mechanisms in the control of respiratory virus infections.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Antibody-independent antiviral function of memory CD4 T cells in vivo requires regulatory signals from CD8 effector T cells

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Quantitative analysis of the CD8 T-cell response to readily eliminated and persistent viruses

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Cell-mediated immunity to respiratory virus infections

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Development of effective vaccines against pandemic influenza.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Enhanced protection against viral infection by co-administration of plasmid DNA coding for viral antigen and cytokines in mice

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Nucleotide sequence changes in the polymerase basic protein 2 gene of temperature-sensitive mutants of influenza A virus

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

More antibody with less antigen: can immunogenicity of attenuated live virus vaccines be improved?

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Activation of influenza virus-specific CD4 and CD8 T cells: a new role for plasmacytoid dendritic cells in adaptive immunity

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Down-modulation of responses to type I IFN upon T cell activation

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Divergent activities of interferon-alpha subtypes against intracellular hepatitis C virus replication

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2006.10.038

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2006.10.038

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44571000&oldid=2028450481"